• Home>
  • Stocks>
  • Syncom Formulations (India) Ltd Share Price
Syncom Formulations (India) Ltd share price logo

Syncom Formulations (India) Ltd Share Price

NSE: SYNCOMF

BSE: 524470

Small Cap

Healthcare Sector

₹15.87

-0.13

(-0.81%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Syncom Formulations (India) Ltd Stock Performance

as on November 21, 2025 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹15.8
    ₹16.06
    downward going graph

    0.44%

    Downside

    1.20%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹14.1
    ₹23.87
    downward going graph

    11.15%

    Downside

    50.41%

    Upside

    downward going graph

Syncom Formulations (India) Ltd share price movements today

Previous Close
₹16.00
Open
₹16.00
Volume
10.55L
Upper Circuit
₹19.20
Lower Circuit
₹12.80
Day's Low - High
₹15.8 - ₹16.06
52 Week Low - High
₹14.1 - ₹23.87

Syncom Formulations (India) Ltd Historical Returns

1 Month Return
-4.59 %
3 Month Return
-8.05 %
1 Year Return
-19.07 %
3 Year Return
+ 101.26 %
5 Year Return
+ 733.33 %

Syncom Formulations (India) Ltd Fundamentals

as on November 21, 2025 at 4:01 pm IST

Market Cap

₹1,504.00 Cr

Return on Equity (ROE)

15.6

PE Ratio (TTM)

23.19

Return on capital employed (ROCE)

18.44

Industry PE ratio

42.05

Beta (LTM)

1.23

P/B Ratio

4.54

Dividend Yield

0

PEG Ratio

100.82

Quarterly Earnings Growth YOY

49.41

EPS (TTM)

0.53

Sector

Pharmaceuticals

Book Value

3.64

Technical Analysis

Bearish

View Technical Analysis

Syncom Formulations (India) Ltd Stock Valuation

as on November 21, 2025 at 4:01 pm IST

Syncom Formulations (India) Ltd in the last 5 years

  • Overview

  • Trends

Lowest (3.98x)

March 12, 2020

Today (23.19x)

November 20, 2025

Industry (42.05x)

November 20, 2025

Highest (81.74x)

January 18, 2022

LowHigh

Today’s Price to Earnings Ratio: 23.19x

Syncom Formulations (India) Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Syncom Formulations (India) Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Syncom Formulations (India) Ltd image
Syncom Formulations (India) Ltd
NA1,504.00146.67%0.5149465
ANG Lifesciences India Ltd image
ANG Lifesciences India Ltd
NA36.80-0.99%0.78-1392
Akums Drugs & Pharmaceuticals Ltd image
Akums Drugs & Pharmaceuticals Ltd
BUY6,634.94-9.41%0.533434,118
Ishita Drugs & Industries Ltd image
Ishita Drugs & Industries Ltd
NA20.9341.68%0.00NA15
Themis Medicare Ltd image
Themis Medicare Ltd
NA1,035.4547.65%0.5929405
See all

Syncom Formulations (India) Ltd Stock’s Investor Sentiment and Interest

Investment in Syncom Formulations (India) Ltd Shares on INDmoney has dropped by -6.81% over the past 30 days, indicating reduced transactional activity.

Time period: to

Change:-6.81% versus previous 30 day period

Search interest for Syncom Formulations (India) Ltd Stock has increased by 39% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:39% versus previous 30 day period

Syncom Formulations (India) Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Sales
57.38
60.98
59.84
63.84
65.14
74.57
87.26
102.31
127.53
148.88
116.9
121.72
Other Income
1.98
6.78
1.87
4
4.56
3.1
1.34
4.15
4.04
6.95
6.08
5.25
Total Income
59.36
67.76
61.71
67.84
69.69
77.67
88.59
106.46
131.57
155.83
122.98
126.97
Expenses
51.48
55.02
53.38
57.43
57.81
65.15
76.8
90.16
112.8
131.12
101.09
103.32
Operating Profit
5.9
5.96
6.46
6.41
7.33
9.42
10.46
12.15
14.73
17.76
15.81
18.4
Operating Profit Margin %
10.28%
9.77%
10.8%
10.04%
11.25%
12.63%
11.99%
11.88%
11.55%
11.93%
13.52%
15.12%
Profit Before Interest, Tax and Depreciation
7.88
12.74
8.33
10.4
11.89
12.52
11.79
16.31
18.77
24.7
21.88
23.65
Interest
0.72
1.29
1.12
1.08
1.08
1.2
0.39
0.16
0.2
0.12
0.25
0.26
Depreciation
1.2
1.17
1.1
0.88
1.45
1.3
1.3
1.3
1.31
1.29
1.34
1.35
Profit Before Tax
5.96
10.28
6.11
8.44
9.36
10.02
10.1
14.85
17.26
23.29
20.29
22.04
Tax Paid
1.82
1.81
1.71
1.94
2.36
2.62
2.47
3.74
4.26
5.61
4.54
5.44
Profit After Tax
4.14
8.47
4.4
6.51
7
7.4
7.63
11.11
13
17.69
15.75
16.6
Total Net profit including share of profit / Loss from associate company
4.14
8.47
4.4
6.51
7
7.4
7.63
11.11
13
17.69
15.75
16.6
EPS
0.06
0.1
0.07
0.08
0.09
0.1
0.11
0.16
0.14
0.16
0.21
0.18
Actual EPS
0.06
0.1
0.07
0.08
0.09
0.1
0.11
0.16
0.14
0.16
0.21
0.18
Adjusted EPS
0.06
0.1
0.07
0.08
0.09
0.1
0.11
0.16
0.14
0.16
0.21
0.18
Diluted EPS
0.06
0.1
0.07
0.08
0.09
0.1
0.11
0.16
0.14
0.16
0.21
0.18

Syncom Formulations (India) Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
182.75
219.66
224.25
263.39
465.01
Other Income
4.86
12.02
14.61
13.53
17.44
Total Income
187.61
231.68
238.87
276.91
482.45
Expenses
168.33
199.63
204.62
233.76
410.88
Operating Profit
14.42
20.03
19.63
29.63
54.13
Operating Profit Margin %
7.89%
9.12%
8.75%
11.25%
11.64%
Profit Before Interest, Tax and Depreciation
19.28
32.05
34.24
43.15
71.57
Interest
0.28
1.93
3.13
4.47
0.86
Depreciation
3.12
3.95
4.54
4.72
5.19
Profit Before Tax
15.88
26.17
26.57
33.96
65.52
Tax Paid
5.34
6.39
6.5
8.63
16.07
Profit After Tax
10.53
19.79
20.07
25.31
49.43
Total Net profit including share of profit / Loss from associate company
10.53
19.79
20.07
25.31
49.43
EPS
0.13
0.26
0.24
0.34
0.57
Actual EPS
0.13
0.26
0.24
0.34
0.57
Adjusted EPS
0.13
0.26
0.24
0.34
0.57
Diluted EPS
0.13
0.24
0.24
0.34
0.57

Syncom Formulations (India) Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
24.07
13.84
16.33
10.53
-5.96
23.44
Cash Flow from Investing Activities
-20.28
-6.89
-27.07
-44.95
83.02
-18.21
Cash Flow from Financing Activities
-2.41
4.67
8.29
35
-14.55
-67.9
Net Cash Flow
-1.08
0.83
-2.45
0.58
62.5
-62.67

Syncom Formulations (India) Ltd Stock Shareholding Pattern

Numbers in percentages

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Promoters
50.57%
50.57%
50.57%
50.57%
50.57%
50.57%
50.57%
50.57%
50.57%
50.57%
50.57%
50.57%
FII
0%
0%
0%
0%
0%
0.08%
0.09%
0.1%
0.13%
0.11%
0.41%
0.1%
Public
49.43%
49.43%
49.43%
49.43%
49.43%
49.35%
49.34%
49.33%
49.3%
49.32%
49.02%
49.33%
Total Outstanding Shares
94,00,00,000
94,00,00,000
94,00,00,000
94,00,00,000
94,00,00,000
94,00,00,000
94,00,00,000
94,00,00,000
94,00,00,000
94,00,00,000
94,00,00,000
94,00,00,000
Total Shareholders
2,32,069
2,27,478
2,24,925
2,24,252
2,89,982
3,25,761
3,76,530
4,69,242
4,89,520
4,84,529
4,71,066
4,57,364

Mutual Funds that own Syncom Formulations (India) Ltd Stock

Check out the Mutual Funds with significant holdings in Syncom Formulations (India) Ltd.

Funds
Holdings
Shares Held
Bandhan BSE Healthcare Index Fund Direct Growth
Bandhan BSE Healthcare Index Fund Direct Growth
0.06%
6247

Syncom Formulations (India) Ltd Corporate Actions

View detailed summary of the earnings and dividend history of Syncom Formulations (India) Ltd.

  • Syncom Formulations (India) Ltd Earnings Results

    Syncom Formulations (India) Ltd’s net profit jumped 49.41% since last year same period to ₹16.60Cr in the Q2 2025-2026. On a quarterly growth basis, Syncom Formulations (India) Ltd has generated 5.4% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Syncom Formulations (India) Ltd Dividends August,2022

    In the quarter ending June 2022, Syncom Formulations (India) Ltd has declared dividend of ₹0.03 per share on 13 Aug 2022 - translating a dividend yield of 0.19%.

    Read More about Dividends

Indices Featuring Syncom Formulations (India) Ltd Stock

Check stock indices that include Syncom Formulations (India) Ltd.

BSE Healthcare

₹44,395.66

-0.5 (▲-221.27%)

BSE Small-Cap

₹52,011.66

-1.3 (▲-683.73%)

Insights on Syncom Formulations (India) Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 15.75 Cr → 16.6 Cr (in ₹), with an average increase of 5.1% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 122.98 Cr → 126.97 Cr (in ₹), with an average increase of 3.1% per quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 49.02% to 49.33% in Sep 2025 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 50.57% of holdings in Sep 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 20.0% return, outperforming this stock by 39.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 129.0% return, outperforming this stock by 27.7%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 0.41% to 0.10% in Sep 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, SYNCOMF stock has moved down by -3.5%

About Syncom Formulations (India) Ltd

Syncom Formulations India is a public limited company that was established in 1988 and converted to public limited in 1992. It manufactures pharmaceutical formulations, injectibles, ear/eye drops, and herbal products such as Edicare Attom Megacaps Ecziguard and Yas antacid salt. The company started its expansion project in 1994 of setting up a new manufacturing plant in Pithampur Madhya Pradesh which was completed in 1995. During the financial year 1998-99, big expansions in the installed capacity and production base, and the introduction of products in the generic OTC and Ethical divisions were made. The exports boasted an increase of more than 100% and received orders worth Rs.700 lacs. It has been approved as a supplier to Central ESI Hospitals and registered for defence services that will augment the sales volume. Syncom Formulations India is continuously working towards growth and aims to significantly increase its product portfolio and customer base.

Revenue: ₹121.72Cr as on September 2025 (Q2 FY26)
Net Profit: ₹16.60Cr as on September 2025 (Q2 FY26)
Listing date: 18 Nov, 2022
Chairperson Name: Kedarmal Bankda
OrganisationSyncom Formulations (India) Ltd
HeadquartersIndore
IndustryPharmaceuticals
CEOKedarmal Bankda
E-voting on sharesClick here to vote

FAQs

What is Syncom Formulations (India) Ltd share price today?

Syncom Formulations (India) Ltd share price today stands at ₹15.87 as on at the close of the market. Syncom Formulations (India) Ltd share today touched a day high of ₹16.06 and a low of ₹15.8.

What is the 52 week high and 52 week low range for Syncom Formulations (India) Ltd share?

Syncom Formulations (India) Ltd touched a 52 week high of ₹23.87 and a 52 week low of ₹14.1. Syncom Formulations (India) Ltd share price today i.e. is closed at ₹15.87, which is -33.51% down from its 52 week high and 12.55% up from its 52 week low.

What is Syncom Formulations (India) Ltd's market capitalisation today?

Syncom Formulations (India) Ltd market capitalisation is ₹1,504.00 Cr as on .

How to buy Syncom Formulations (India) Ltd shares?

To buy Syncom Formulations (India) Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for SYNCOMF or Syncom Formulations (India) Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Syncom Formulations (India) Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Syncom Formulations (India) Ltd trading volume today?

Syncom Formulations (India) Ltd trading volume is 10.55L as on . This means that 10.55L shares of Syncom Formulations (India) Ltd were bought and sold on the stock market during today's trading session.